In direct connection to Oasmia's research facility in Uppsala, the company has a modern production plant for chemical synthesis and pharmaceutical manu-facturing.
The facilities have been designed to meet present and future production needs. The entire production process is carried out according to cGMP (current Good Manufacturing Practice) and is quality controlled from organic synthesis, analysis and freeze-drying to filling, labelling and packaging. Our quality assu-rance is an all over continuing process in order to sustain the overall safety of our drug candidates.

